DSM 5 Intro
DSM 5 Intro
DSM 5 Intro
• Since the release of the DSM IV in 1994 – tremendous progress in research (cognitive
neuroscience, brain imaging, epidemiology and genetics)
• Categorical vs. dimensional approach – well defined symptom boundaries vs. symptom
clusters and spectrums
REVISION OF THE DSM-5 – MULTIDISCIPLINARY
APPROACH
• Physicians • Neuroscientists
• Psychologists • Neuropsychologists
• Social workers • Patients’ families
• Counselors • Lawyers
• Nurses • Consumer organizations
• Epidemiologists • Advocacy groups
• Statisticians
A BRIEF DSM HISTORY
• DSM-III-R published in 1987 – 292 categories, leaned towards the role of biology and
genetics in psychological disorders – Kraeplin. Ego-dystonic homosexuality was deleted
• DSM-IV published in 1994 – about 297 diagnostic categories, all disorders were based on
empirical research. The term ‘clinical significance’ was introduced
• DSM-IV-TR – disorders remained unchanged. Only background information and familial
patterns were updated based on recent research. Multiaxial diagnostic system was used
• Axis I – clinical syndromes
• Axis II – personality and developmental disorders
• Axis III – general medical conditions
• Axis IV – psychosocial and environmental issues
• Axis V – Global Assessment of Functioning
DSM-5 REVISION PROCESS
• 12 year process beginning in 1999 when the APA evaluated strengths and weaknesses of
the DSM
• The APA coordinated with the WHO, the WPA and the NIMH to organize a series of
conferences, the proceedings of which were published in a monograph – ‘A Research
Agenda for DSM-V’
• 13 international DSM research planning conferences were organized subsequently, to
prepare for revisions of both DSM and ICD
• DSM-5 Task Force was set up with a multidisciplinary range of expertise
• David Kupfer, University of Pittsburgh (Chair), Darell Regier, Director, Division of
Research (Vice-Chair) of the DSM-5 Task Force
DSM-5 REVISION PROCESS
• Efforts were made to avoid conflict of interests (e.g. Listerine, e.g. Alison Bass’ ‘Side
Effects’ and GlaxoSmithKline’s Paxil, Christopher Lane’s ‘Shyness: How Normal Behavior
Became a Sickness’)
• Novel scientific findings for the last 2 decades were considered
• 4 principles to guide revision –
• Revision must be feasible to use in routine clinical practice
• Revision should be guided by research evidence
• Continuity should be maintained with previous editions of DSM
• There should not be any constraints on the degree of change between DSM-IV and DSM-5
OVERVIEW OF THE DSM-5, MAY 2013
• 3 sections
I. Introduction and use of the manual
• Review of development
• Goals
• Changes
• Non-axial diagnostic format
II. Diagnosis and revised chapter organization
III. Emerging measures and models
• Conditions requiring further research
• Dimensional measures
• Cultural formation
• Glossary